Determining the anti-coagulant-independent anti-cancer effects of heparin
- PMID: 20648011
- PMCID: PMC2939791
- DOI: 10.1038/sj.bjc.6605808
Determining the anti-coagulant-independent anti-cancer effects of heparin
Comment on
-
Epidemiology and pathophysiology of cancer-associated thrombosis.Br J Cancer. 2010 Apr 13;102 Suppl 1(Suppl 1):S2-9. doi: 10.1038/sj.bjc.6605599. Br J Cancer. 2010. PMID: 20386546 Free PMC article. Review.
-
Antithrombotic therapy and survival in patients with malignant disease.Br J Cancer. 2010 Apr 13;102 Suppl 1(Suppl 1):S24-9. doi: 10.1038/sj.bjc.6605602. Br J Cancer. 2010. PMID: 20386547 Free PMC article. Review.
References
-
- Bishop JR, Schuksz Esko JD (2007) Heparan sulphate proteoglycans fine-tune physiology. Nature 446: 1030–1037 - PubMed
-
- Boccaccio C, Comoglio PM (2005) A functional role for hemostasis in early cancer development. Cancer Res 65: 8579–8582 - PubMed
-
- Cunningham MS, Preston RJ, O’Donnell JS (2009) Does antithrombotic therapy improve survival in cancer patients? Blood Rev 3: 129–135 - PubMed
-
- Dvorak HF (1986) Tumors: wounds that do not heal. NEJM 315: 1650–1659 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical